NCT04977024 2026-02-11SARS-CoV-2 Vaccine (GEO-CM04S1) Versus mRNA SARS-COV-2 Vaccine in Patients With Blood CancerGeoVax, Inc.Phase 2 Active not recruiting63 enrolled